Home » Stocks » NSPX

Inspyr Therapeutics, Inc. (NSPX)

Stock Price: $0.0095 USD 0.0000 (2.15%)
Updated Jan 26, 2021 11:10 AM EST - Market open
Market Cap 1.03M
Revenue (ttm) n/a
Net Income (ttm) -291,000
Shares Out 13.34M
EPS (ttm) -0.17
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 26
Last Price $0.0095
Previous Close $0.0093
Change ($) 0.0000
Change (%) 2.15%
Day's Open 0.0090
Day's Range 0.0085 - 0.0098
Day's Volume 11,787,210
52-Week Range 0.0005 - 0.7

News

Accesswire - 2 weeks ago

Proceeds support the development of lead asset, RT-AR001, an adenosine receptor antagonist Funds were secured from an existing institutional investor WESTLAKE VILLAGE, CA / ACCESSWIRE / Januar...

About NSPX

Inspyr Therapeutics, clinical-stage pharmaceutical company, focuses on the development of therapeutics for the treatment of diseases. It focuses on a pipeline of small molecule adenosine receptor modulators, such as A2B antagonists, dual A2A/A2B antagonists, and A2A agonists. The company was formerly known as GenSpera Inc. and changed its name to Inspyr Therapeutics, Inc. in August 2016. Inspyr Therapeutics, Inc. was founded in 2003 and is based in Westlake Village, California.

Industry
Biotechnology
Founded
2003
CEO
Michael Cain
Employees
1
Stock Exchange
OTCMKTS
Ticker Symbol
NSPX
Full Company Profile

Financial Performance

Financial Statements